Información del artículo
El Texto completo está disponible en PDF
References
[1.]
B. Greenstein, D. Wood.
The endocrine system at a glance.
2nd ed., Wiley, (2006),
[2.]
J. Vague.
The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease.
Am J Clin Nutr, 4 (1956), pp. 20-34
[3.]
A.H. Kissebah, G.R. Krakower.
Regional adiposity and morbidity.
Physiological Reviews, 74 (1994), pp. 761-809
[4.]
P.J. Randle, P.B. Garland, C.N. Hales, E.A. Newsholme.
The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.
Lancet, 1 (1963), pp. 785-789
[5.]
E. Ferrannini, E.J. Barrett, S. Bevilacqua, R.A. DeFronzo.
Effect of fatty acids on glucose production and utilization in man.
J Clin Invest, 72 (1983), pp. 1737-1747
[6.]
K. Frayn, S. Humphreys, S. Coppack.
Net carbon flux across subcutaneous adipose tissue after a standard meal in normal weight and and insulin resistant obese subjects.
Int J Obes Rel Metab Disord, 20 (1996), pp. 795-800
[7.]
F. Lönnqvist, A. Thörne, K. Nilsell, J. Hoffstedt, P. Arner.
A pathogenic role of visceral β3-adrenoceptors in obesity.
J Clin Invest, 95 (1995), pp. 1109-1116
[8.]
V. Van Harmelen, F. Lonnqvist, A. Thorne, A. Wennlund, V. Large, S. Reynisdottir, et al.
Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
Int J Obes Relat Metab Disord, 21 (1997), pp. 972-979
[9.]
P.M. Stewart, A. Boulton, S. Kumar, P.M.S. Clark, C.H.L. Shackleton.
Cortisol metabolism in human obesity: impaired cortisone–cortisol conversion in subjects with central adiposity.
J Clin Endocrinol Metab, 84 (1999), pp. 1022-1027
[10.]
E. Ravussin, S.R. Smith.
Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus.
Ann N Y Acad Sci, 967 (2002), pp. 363-378
[11.]
G.F. Lewis, A. Carpentier, K. Adeli, A. Giacca.
Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
Endocr Rev, 23 (2002), pp. 201-229
[12.]
R.S. Ahima, J.S. Flier.
Adipose tissue as an endocrine organ.
Trends Endocrinol Metab, 11 (2000), pp. 327-332
[13.]
J. Westerbacka, H. Yki-Järvinen, S. Vehkavaara, A.M. Häkkinen, R. Andrew, D.J. Wake, et al.
Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
J Clin Endocrinol Metab, 88 (2003), pp. 4924-4931
[14.]
J.J. Senn, P.J. Klover, I.A. Nowak, R.A. Mooney.
Interleukin-6 induces cellular insulin resistance in hepatocytes.
Diabetes, 51 (2002), pp. 3391-3399
[15.]
J. Hirosumi, G. Tuncman, L. Chang, C.Z. Görgün, K.T. Uysal, K. Maeda, et al.
A central role for JNK in obesity and insulin resistance.
Nature, 420 (2002), pp. 333-336
[16.]
H. Xu, G.T. Barnes, Q. Yang, G. Tang, D. Yang, C.J. Chou, et al.
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.
J Clin Invest, 112 (2003), pp. 1821-1830
[17.]
S.P. Weisberg, D. Mc Cann, M. Desai, M. Rosenbaum, R.L. Leibel, A.W.J. Ferrante.
Obesity is associated with macrophage accumulation in adipose tissue.
J Clin Invest, 112 (2003), pp. 1796-1808
[18.]
C.T. Montague, J.B. Prins, L. Sanders, J. Zhang, C.P. Sewter, J. Digby, et al.
Depot-related gene expression in human subcutaneous and omental adipocytes.
Diabetes, 47 (1998), pp. 1384-1391
[19.]
Y. Wang, E.B. Rimm, M.J. Stampfer, W.C. Willett, F.B. Hu.
Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men.
Am J Clin Nutr, 81 (2005), pp. 555-563
[20.]
C. De Luca, J.M. Olefsky.
Inflammation and insulin resistance.
FEBS Lett, 582 (2008), pp. 97-105
Copyright © 2009. Sociedad Española de Endocrinología y Nutrición
